Does obstructive sleep apnea–related intermittent hypoxia increase erythropoietin signaling and iron demand?

Obstructive sleep apnea (OSA) creates a unique physiological state where repetitive cycles of nocturnal oxygen desaturation trigger compensatory hematological changes. Research indicates that the resulting intermittent hypoxia serves as a potent stimulus for erythropoiesis, fundamentally altering red blood cell production and iron metabolism.

Clinical evidence and hematological impact

Evidence consistently demonstrates that the severity of OSA correlates with elevations in red blood cell indices. Clinical data show that hemoglobin and hematocrit levels rise progressively with the severity of the Apnea-Hypopnea Index (AHI), particularly in severe cases (AHI > 30).

• Polycythemia Risk: Secondary polycythemia—an abnormally high concentration of red blood cells—is observed in approximately 6% of patients with severe OSA.
• CPAP Response: The causal link is reinforced by the effect of Continuous Positive Airway Pressure (CPAP) therapy. Resolution of intermittent hypoxia via CPAP results in a significant reduction of hemoglobin (mean decrease of 3.76 g/L) and hematocrit (mean decrease of 1.1%).
• Demographics: These relationships are notably pronounced in men, where nocturnal mean oxygen saturation shows a strong inverse correlation with red blood cell indices.

Mechanistic explanations

The transition from airway obstruction to increased red cell mass involves a complex molecular signaling cascade:

• HIF-1α Stabilization: Intermittent hypoxia triggers the stabilization of Hypoxia-Inducible Factor 1-alpha (HIF-1α). Under normal oxygen levels, HIF-1α is degraded, but OSA allows it to accumulate and bind to hypoxia response elements in the erythropoietin (EPO) gene promoter.
• EPO Signaling: This binding stimulates renal synthesis of EPO. While clinical measurements of EPO in OSA patients can be variable—potentially due to the timing of blood draws relative to the hypoxic events—the underlying pathway for stimulated erythropoiesis is well-established.
• Iron Demand: Accelerated red blood cell formation increases the demand for iron, a critical substrate for heme synthesis. This heightened demand often outpaces iron mobilization, leading to functional iron deficiency. Patients frequently exhibit decreased transferrin saturation (%TS), reflecting that iron consumption for new red cells exceeds the rate of iron release from storage.
• Hepcidin Influence: The process is further complicated by the upregulation of hepcidin, driven by both hypoxia and systemic inflammation, which restricts iron availability by inhibiting ferroportin-mediated release.

Bottom line

Obstructive sleep apnea drives a compensatory increase in red blood cell production via the HIF-1α/EPO pathway. This process raises hemoglobin and hematocrit levels—potentially leading to secondary polycythemia—while simultaneously increasing iron demand and depleting accessible iron stores.